These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30819257)

  • 1. Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease.
    Liu H; Lyu Y; Li D; Cui Y; Huang Y; Dai W; Li Y
    Cardiovasc Diabetol; 2019 Feb; 18(1):21. PubMed ID: 30819257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential associations of circulating growth differentiation factor-15 with sex hormones in male patients with coronary artery disease.
    Liu H; Dai W; Cui Y; Lyu Y; Li Y
    Biomed Pharmacother; 2019 Jun; 114():108792. PubMed ID: 30909145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
    Wang X; Chen LL; Zhang Q
    Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of circulating growth differentiation factor-15, Krüppel-like factor 4 and growth arrest-specific 6 with coronary artery disease.
    Liu H; Lyu YN; Li D; Cui Y; Dai W; Li Y
    Clin Chim Acta; 2019 Aug; 495():630-636. PubMed ID: 31153870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
    Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
    Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.
    Ozdemir E; Stavileci B; Ozdemir B; Aksoy FA; Kahraman S; Colakoglu Gevher CZ; Ziyrek M; Dogan A
    Adv Med Sci; 2024 Mar; 69(1):56-60. PubMed ID: 38368744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease.
    Li M; Duan L; Cai YL; Li HY; Hao BC; Chen JQ; Liu HB
    Cardiovasc Diabetol; 2020 Aug; 19(1):120. PubMed ID: 32746821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, ischemia modified albumin and pregnancy-associated plasma protein A in patients with coronary artery disease.
    Fan LY; Jin ZG; Zong M; Wang QZ; Ju Y; Sun LS; Gu YY; Yu P; Zhang DF; Liu ZM
    Clin Lab; 2014; 60(6):973-82. PubMed ID: 25016703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of sgp130 and sex hormones in male patients with coronary atherosclerotic disease.
    Cui Y; Dai W; Li Y
    Atherosclerosis; 2017 Nov; 266():151-157. PubMed ID: 29028483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study.
    Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Masunaga N; Ishii M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2020 Nov; 9(22):e018217. PubMed ID: 33170061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
    Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Growth Differentiation Factor-15 in Patients with or without Coronary Artery Disease.
    Hassanzadeh Daloee S; Nakhaei N; Hassanzadeh Daloee M; Mahmoodi M; Barzegar-Amini M
    Acta Biomed; 2021 May; 92(2):e2021051. PubMed ID: 33988174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia.
    Cheng J; Lyu Y; Mei Y; Chen Q; Liu H; Li Y
    Lipids Health Dis; 2023 Mar; 22(1):31. PubMed ID: 36864452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
    Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus.
    Mei Y; Zhao Z; Lyu Y; Li Y
    Lipids Health Dis; 2022 Jul; 21(1):59. PubMed ID: 35842724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
    Zhu ZD; Sun T
    Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
    Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
    Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum testosterone level was associated with extensive coronary artery calcification in elderly male patients with stable coronary artery disease.
    Lai J; Ge Y; Shao Y; Xuan T; Xia S; Li M
    Coron Artery Dis; 2015 Aug; 26(5):437-41. PubMed ID: 25968306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.